These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11194736)

  • 1. How many dependent heroin users are there in Australia?
    Hall WD; Ross JE; Lynskey MT; Law MG; Degenhardt LJ
    Med J Aust; 2000 Nov; 173(10):528-31. PubMed ID: 11194736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back-projection estimates of the number of dependent heroin users in Australia.
    Law MG; Lynskey M; Ross J; Hall W
    Addiction; 2001 Mar; 96(3):433-43. PubMed ID: 11255583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
    Darke S; Ross J; Lynskey M; Teesson M
    Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
    Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia.
    Humeniuk R; Ali R; McGregor C; Darke S
    Addiction; 2003 Apr; 98(4):413-8. PubMed ID: 12653811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
    Degenhardt L; Day C; Conroy E; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Sep; 79(3):397-404. PubMed ID: 15927418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect estimates of 'hidden' populations: capture-recapture methods to estimate the numbers of heroin users in the Australian Capital Territory.
    Larson A; Stevens A; Wardlaw G
    Soc Sci Med; 1994 Sep; 39(6):823-31. PubMed ID: 7973878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Number of Heroin Users in Metropolitan France Using Treatment Centers Data: An Exploratory Analysis.
    Janssen E
    Subst Use Misuse; 2017 Apr; 52(5):683-687. PubMed ID: 28026979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "lessons" of the Australian "heroin shortage".
    Degenhardt L; Day C; Gilmour S; Hall W
    Subst Abuse Treat Prev Policy; 2006 May; 1():11. PubMed ID: 16722543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
    Gibson A; Randall D; Degenhardt L
    Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995.
    Zador D; Sunjic S
    Addiction; 2000 Jan; 95(1):77-84. PubMed ID: 10723832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin users in Australia: population trends.
    Kaya CY; Tugai Y; Filar JA; Agrawal MR; Ali RL; Gowing LR; Cooke R
    Drug Alcohol Rev; 2004 Mar; 23(1):107-16. PubMed ID: 14965892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS).
    Darke S; Topp I; Kaye H; Hall W
    Addiction; 2002 Feb; 97(2):179-86. PubMed ID: 11860389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.
    Teesson M; Havard A; Fairbairn S; Ross J; Lynskey M; Darke S
    Drug Alcohol Depend; 2005 Jun; 78(3):309-15. PubMed ID: 15893162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.